Thanks. I would credit "acquired after NDA was already filed" new drugs to small companies even if they were owned by big companies at time of approval. Either

Thanks. I would credit "acquired after NDA was already filed" new drugs to small companies even if they were owned by big companies at time of approval. Either way, if 12 out of 21 small-company drugs were developed all the way to the way to approval without bigger companies, my earlier guess that the majority required big company help to finish was incorrect.